Literature DB >> 909397

Triiodothyronine and thyroxine content of desiccated thyroid tablets.

R W Rees-Jones, P R Larsen.   

Abstract

Triiodothyronine (T3) and thyroxine (T4) were measured by radioimmunoassay in Pronase hydrolysates of four lots each of 1- and 2-grain tablets of desiccated thyroid (Thyroid, Armour) and thyroglobulin (Proloid, Warner-Chilcott). The methodology used was verified by studies of tablets containing known quantities of T4 and T3. One grain of desiccated thyroid contained 12 +/- 1 and 64 +/- 3 microgram (mean +/- SD) of T3 and T4 per tablet, respectively (T4/T3 molar ratio, 4.3). A 1-grain tablet of thyroglobulin contained 16 +/- 2 and 55 +/- 5 microgram of T3 and T4, respectively with a T4/T3 ratio of 2.9. Two-grain tablets generally contained twice the quantity of T3 and T4 in the 1-grain preparations. The variation in T3 and T4 content between the four lots of each tablet strength for each product was 10% or less. These estimates of T3 and T4 content are 1.5- to 2-fold greater than those previously published. This difference probably results from the more sophisticated methodology now available which does not require chromatographic separation of T3 and T4 or iodometry. Using calculations based on published estimates of T4 and T3 absorption and of the T3/T4 potency ratio, it would appear that the T3 content of desiccated thyroid and thyroglobulin provide approximately 39% and 51%, respectively, of the thyromimetic activity of these two medications.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 909397     DOI: 10.1016/0026-0495(77)90113-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Unintentional thyrotoxicosis factitia due to a diet pill.

Authors:  G D Braunstein; R Koblin; M Sugawara; A E Pekary; J M Hershman
Journal:  West J Med       Date:  1986-09

2.  Thyroid supplements: effect on bone mass.

Authors:  B Ettinger; J Wingerd
Journal:  West J Med       Date:  1982-06

Review 3.  Overt and subclinical hypothyroidism: who to treat and how.

Authors:  Deepak Khandelwal; Nikhil Tandon
Journal:  Drugs       Date:  2012-01-01       Impact factor: 11.431

4.  Trends in thyroid hormone prescribing and consumption in the UK.

Authors:  Anna L Mitchell; Bryan Hickey; Janis L Hickey; Simon H S Pearce
Journal:  BMC Public Health       Date:  2009-05-11       Impact factor: 3.295

5.  Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life.

Authors:  Anam Tariq; Yijin Wert; Pramil Cheriyath; Renu Joshi
Journal:  South Med J       Date:  2018-06       Impact factor: 0.954

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.